These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
144 related items for PubMed ID: 6690042
21. Design of liposomes to improve delivery of macrophage-augmenting agents to alveolar macrophages. Fidler IJ, Raz A, Fogler WE, Kirsh R, Bugelski P, Poste G. Cancer Res; 1980 Dec; 40(12):4460-6. PubMed ID: 7002293 [Abstract] [Full Text] [Related]
22. Effects on the monocyte-macrophage system and antitumor activity against L1210 leukemia of cis-bis-cyclopentenecarboxylato-trans-R,R-1,2-diaminocyclohexane -platinum (II) encapsulated in multilamellar vesicles. Perez-Soler R, Khokhar AR, Claringbold P, Kasi LP, Lopez-Berestein G. J Natl Cancer Inst; 1986 Nov; 77(5):1137-43. PubMed ID: 2430132 [Abstract] [Full Text] [Related]
23. The activation of tumoricidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators. Fogler WE, Talmadge JE, Fidler IJ. J Reticuloendothel Soc; 1983 Mar; 33(3):165-74. PubMed ID: 6834360 [Abstract] [Full Text] [Related]
24. Synergism between lymphokines and muramyl dipeptide encapsulated in liposomes: in situ activation of macrophages and therapy of spontaneous cancer metastases. Fidler IJ, Schroit AJ. J Immunol; 1984 Jul; 133(1):515-8. PubMed ID: 6373933 [Abstract] [Full Text] [Related]
25. Activation of alveolar macrophage tumoricidal activity and eradication of experimental metastases by freeze-dried liposomes containing a new lipophilic muramyl dipeptide derivative. Phillips NC, Moras ML, Chedid L, Lefrancier P, Bernard JM. Cancer Res; 1985 Jan; 45(1):128-34. PubMed ID: 3838084 [Abstract] [Full Text] [Related]
26. Comparison of the in vitro cytolytic effect of hepatic, splenic and peritoneal macrophages from glucan-treated mice on sarcoma M5076. Sherwood ER, Williams DL, Di Luzio NR. Methods Find Exp Clin Pharmacol; 1986 Mar; 8(3):157-61. PubMed ID: 3713379 [Abstract] [Full Text] [Related]
27. Effects of recombinant alpha-interferon-gelatin conjugate on in vivo murine tumor cell growth. Tabata Y, Uno K, Yamaoka T, Ikada Y, Muramatsu S. Cancer Res; 1991 Oct 15; 51(20):5532-8. PubMed ID: 1833052 [Abstract] [Full Text] [Related]
28. Multiple tumoricidal effector mechanisms induced by adriamycin. Salazar D, Cohen SA. Cancer Res; 1984 Jun 15; 44(6):2561-6. PubMed ID: 6327018 [Abstract] [Full Text] [Related]
29. Modulatory effect of killed Propionibacterium acnes and its purified soluble polysaccharide on peritoneal exudate cells from C57Bl/6 mice: major NKT cell recruitment and increased cytotoxicity. Ananias RZ, Rodrigues EG, Braga EG, Squaiella CC, Mussalem JS, Longhini AL, Travassos LR, Longo-Maugéri IM. Scand J Immunol; 2007 Jun 15; 65(6):538-48. PubMed ID: 17523946 [Abstract] [Full Text] [Related]
30. Preparation and antitumor effect of macrophage activating factor (MAF) encapsulated in liposomes bearing a monoclonal anti-human melanoma (A375) antibody. Watanabe Y, Uchida E, Higuchi M, Imai Y, Osawa T. J Biol Response Mod; 1987 Oct 15; 6(5):556-68. PubMed ID: 3316511 [Abstract] [Full Text] [Related]
31. [Induction of the tumoricidal activity of human and murine peritoneal macrophages under the action of antitumor chemical preparations]. Potapov SL, Viadro MM. Biull Eksp Biol Med; 1989 Sep 15; 108(9):330-2. PubMed ID: 2611394 [Abstract] [Full Text] [Related]
32. The role of plasma membrane receptors and the kinetics of macrophage activation by lymphokines encapsulated in liposomes. Fidler IJ, Raz A, Fogler WE, Hoyer LC, Poste G. Cancer Res; 1981 Feb 15; 41(2):495-504. PubMed ID: 7004633 [Abstract] [Full Text] [Related]
33. Human alveolar macrophages: potentiation of their tumoricidal activity by liposome-encapsulated muramyl dipeptide. Sone S, Tsubura E. J Immunol; 1982 Sep 15; 129(3):1313-7. PubMed ID: 7108208 [Abstract] [Full Text] [Related]
34. Association of macrophage activation with antitumor effect on rat syngeneic fibrosarcoma by Nocardia rubra cell wall skeleton. Ogura T, Namba N, Hirao F, Yamamura Y, Azuma I. Cancer Res; 1979 Nov 15; 39(11):4706-12. PubMed ID: 498096 [Abstract] [Full Text] [Related]
35. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage. Colotta F, Peri G, Villa A, Mantovani A. J Immunol; 1984 Feb 15; 132(2):936-44. PubMed ID: 6690624 [Abstract] [Full Text] [Related]
36. Immunoregulation by macrophages II. Separation of mouse peritoneal macrophages having tumoricidal and bactericidal activities and those secreting PGE and interleukin I. Hopper KE, Cahill JM. J Reticuloendothel Soc; 1983 Jun 15; 33(6):443-56. PubMed ID: 6602218 [Abstract] [Full Text] [Related]
37. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570). Liepins A, Nowicky JW. Drugs Exp Clin Res; 1996 Jun 15; 22(3-5):103-13. PubMed ID: 8899312 [Abstract] [Full Text] [Related]
38. Inhibition of lymphokine-induced macrophage microbicidal activity against Leishmania major by liposomes: characterization of the physicochemical requirements for liposome inhibition. Gilbreath MJ, Hoover DL, Alving CR, Swartz GM, Meltzer MS. J Immunol; 1986 Sep 01; 137(5):1681-7. PubMed ID: 3745916 [Abstract] [Full Text] [Related]
39. Enhanced activity of mouse peritoneal cells after aclacinomycin administration. Cuellar AB, Algara DS, Metzger G, Orbach-Arbouys S. Cancer Res; 1987 Jul 01; 47(13):3477-84. PubMed ID: 3034418 [Abstract] [Full Text] [Related]
40. Hyaluronan-modified and regular multilamellar liposomes provide sub-cellular targeting to macrophages, without eliciting a pro-inflammatory response. Glucksam-Galnoy Y, Zor T, Margalit R. J Control Release; 2012 Jun 10; 160(2):388-93. PubMed ID: 22019559 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]